Alpha Teknova, Inc. and Pluristyx, Inc. announced a collaboration to produce and commercialize Pluristyx's PluriFreeze™ product line. This system, comprising a cryopreservative and cell wash media, is designed for customers developing allogeneic cell therapies.
Under the terms of the collaboration, Teknova will serve as the exclusive manufacturer and distributor of the PluriFreeze product line in the United States and Canada. This partnership leverages Teknova's operational and commercial scale with Pluristyx's novel cryopreservation solution.
The PluriFreeze system is entirely synthetic and animal-origin-free, featuring PluriFreeze Base as a protective wash and PluriFreeze PF10 as a low viscosity freezing medium with 10% dimethyl sulfoxide (DMSO). This system aims to simplify the scale-up process for cell therapy manufacturing.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.